Platinum-resistant Ovarian Cancer Recruiting Phase 1 / 2 Trials for Gemcitabine (DB00441)

Also known as: Platinum drug resistant Ovarian cancer / Platinum-resistant Ovarian Cancer (PROC) / Platinum Resistant Ovarian Cancer

IndicationStatusPhase
DBCOND0068919 (Platinum-resistant Ovarian Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05548296A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial CarcinomaTreatment